Arterial Blockage – ST-Elevation Myocardial Infarction (STEMI)

Arterial Blockage – ST-Elevation Myocardial Infarction (STEMI)

An STEMI (ST-elevation myocardial infarction) is the medical term for a serious heart attack. It's typically associated with a blockage in one of the main arteries leading into the heart. In most cases, it's an indication that the patient suffers from artherosclerosis, a form of coronary artery disease.

The diagnosis of a STEMI comes from an electrocardiogram. Individuals suffering from acute STEMI have a significant risk of sudden or massive heart attack caused by arrhythmias, such as ventricular fibrillation. Successful treatment includes defibrillation and CPR (cardiopulmonary resuscitation) to reestablish a normal heart rhythm.

Symptoms of a STEMI

Indications that you may be experiencing an ST-elevation myocardial infarction include:

  • Shortness of breath or difficulty breathing
  • Chest pains
  • Nausea or vomiting
  • Sweatiness unrelated to current temperatures
  • Dizziness or lightheadedness
  • Heart palpitations (a greater sense of the awareness of the beating of your heart)
  • Anxiety

The early signs of STEMI may be similar to those of heartburn or even indigestion. It's best to seek treatment for any abnormality.

Treatment of STEMI

Because of the serious nature of a STEMI, it's typical to take more radical steps in response. Though clot-busting drugs may be administered, an angioplasty or stent is often one of the first measures. With an angioplasty, a "balloon" is surgically implanted and inflated, opening the blocked artery. The optimal time period for the angioplasty is within 90 minutes of the first signs of the STEMI.

If the artherosclerosis is too severe, an angioplasty may not work. In such cases, a patient may require open heart surgery, typically in the form of a coronary artery bypass graft, also known as "bypass surgery."

Related Articles

  • Actos

    Actos

    Actos (pioglitazone) is manufactured by Takeda Pharmaceuticals and was approved by the FDA July 15, 1999, for the treatment of Type-2 diabetes. Marketed by Eli Lilly in the U.S., A Read More...

  • Cancer Related to Breast Implants

    Cancer Related to Breast Implants

    The U.S. Food and Drug Administration (FDA) has given approval to two different types of breast implants for sale in the United States. The breast implants both utilize an exterior Read More...

  • Gadolinium-Based MRI Contrast Agents

    Gadolinium-Based MRI Contrast Agents

    Health Risks Associated with Use of Chemical Element in MRIs For some types of MRI (magnetic resonance imaging) or MRA (magnetic resonance angiography), intravenous drugs must be Read More...

© 2015-2021 LawConnect, Inc. All rights reserved.

CONCEPT, DESIGN and HOSTING BY GETLEGAL.COM’S WEB SERVICES TEAM..